Figure 4.

Methylation analysis of the NDRG2 promoter in 30 tumour and normal tissue pairs, evaluated by the bisulfite sequencing analysis. Data are expressed as the difference in methylation status between tumour and normal tissue.

Piepoli et al. BMC Medical Genomics 2009 2:11   doi:10.1186/1755-8794-2-11
Download authors' original image